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Introduction and objectives: Cardiovascular disease is the main cause of
death in patients with kidney failure.Moreover, the presence of impaired renal
function is an important prognostic factor in patients with heart disease, and is
a determinant of outcome during follow-up. The main aim was to investigate
the relationship between kidney failure at admission and one-year mortality in
patients with Non-ST-elevation acute coronary syndrome.
Patients and methods: We studied 342 consecutive patients admitted in
the military hospital of Constantine and Algiers. The serum creatinine level
and glomerular filtration rate were determined at admission, and classical risk
factors and biochemical markers were assessed. The primary endpoint was all
cause mortality at one year.
Results: Patients who died were older, more frequently had a history of
diabetes or coronary artery disease, were more likely to have heart failure at
admission, had higher troponin-I, myoglobin and creatinine levels, and were
less likely to have dyslipidemia or to be a smoker. Multivariate analysis
showed that the independent predictors of allcause mortality at one year were
age, diabetes, troponin-I level, Killip class >1, male gender, creatinine level,
and glomerular filtration rate. There was a linear correlation between
increased risk and creatinine level.
Conclusions: Creatinine level at admission is one of the most important
covariates in early prognostic stratification in these patients. A high serum cre-
atinine level (or a low glomerular filtration rate) increases the probability of
death due to all causes. The serum creatinine level is, moreover, an inexpen-
sive, easy-touse, and widely available prognostic marker.
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Corrected QT interval prolongation: a new predictor of cardiovascu-
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Introduction and objectives: Recently we reported that prolongation of
the corrected QT (CTc) interval is an independent risk factor in patients with
unstable angina and acute ischemic changes. The aim of this study was to
determine the prognostic value of the corrected QT (CTc) interval in patients
with non-ST-segment elevation acute coronary syndrome who do not exhibit
acute ischemic changes on admission ECG.
Methods: The study included 105 patients with this syndrome. On admis-
sion, a standard 12-lead ECG was recorded, the cardiac troponin-T was mea-
sured and aTIMI (Thrombolysis in Myocardial Infarction) risk score was
calculated. The primary endpoint was the combination of nonfatal acute myo-
cardial infarction, percutaneous or surgical revascularization, and cardiac
death up to 30 days after discharge. Two independent investigators measured
the QT interval manually and the corrected value was derived using Bazett’s
formula. In the statistical analysis, the following cut-off points were used: the
median TIMI risk score, a cardiac troponin-T level of 0.04 ng/mL, and a QTc
of 0.458 s.
Results: Of the 40 patients (38%) who reached the primary endpoint, 32
(80%) had QTc prolongation. Binary logistic regression analysis showed that
QTc prolongation was an independent predictor of the combined endpoint.
Conclusions: This study shows that QTc prolongation is an independent
predictor of cardiovascular risk in patients with non-ST-segment elevation
acute coronary syndrome but without acute ischemic changes on admission
ECG.
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Introduction: Few studies have examined the incidence of the composite
event cardiovascular death and/or myocardial infarction in long term in
patients who presented with acute coronary syndrome with ST segment eleva-
tion (STEMI) treated with fibrinolysis or percutaneous angioplasty.
Methods: This is a prospective longitudinal trial held between August
1997 and September 2011 in La Rabta Hospital. Between August 1997 and
august 2004, were randomly included 146 patients who had had a first non-
fatal myocardial infarction non-fatal during the first 30 days. After a mean
follow up of 9.6 years, we recorded the composite event cardiovascular death
and/or myocardial infarction.
Results: The total number of patients who developed the composite event
cardiovascular death and/or myocardial infarction was 34 (23.3%). The
average time of occurrence of the composite event is 8.4+/–4.1 years. No fac-
tors of the characteristics of the population were significantly associated with
nonfatal myocardial infarction at 10 years in univariate analysis. Factors sig-
nificantly predictive of the composite event cardiovascular death and/or myo-
cardial infarction at 9.6 years in univariate analysis are the same factors
predictive of cardiovascular death age (p=0.002), diabetes (p=0.01) and mul-
tivessel coronary disease (p=0.05). There is a tendency to correlation of the
composite event at 9.6 years with history of hypertension (p=0.06). In multi-
variate analysis, independent factors predictive of the composite event, cardio-
vascular death and/or myocardial infarction are age >55 years (OR=.53, 95%
CI: 1.97, 36.96, p=0.004), diabetes (OR=4.3, 95% CI: 1.31, 14.15, p=0.016)
and the anterior territory of the myocardial infarction (OR=5.5, 95% CI: 1.02,
29.66, p=0.047).
Conclusion: In our population predictors of the composite event cardio-
vascular death and/or myocardial infarction in the multivariate analysis were
age, anterior territory of the infarction and diabetes. Better control and man-
agement could reduce the long-term mortality.
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Background: TIMI Risk Score for ST-elevation myocardial infarction
(STEMI) is a score designed for prediction of mortality occuring 30 days after
a STEMI. It was validated in the literature at 1 years and 5 years after STEMI.
Aim: We applied the TIMI risk score to our cohort of STEMI patients
treated in majority with fibrinolysis to validate the possibility to predict
10 years survival.
Methods: TIMI risk score was developed in a cohort of 146 male Tunisian
(mean age 52.4±9 years) hospitalized during the period 1997 to 2004 with
STEMI treated with fibrinolysis in 68 % of patients and non revascularised
early in 32% of patients. STEMI was diagnosed based on typical criteria:
chest pain or ECG changes and rise in creatinin kinase in all patients. We
excluded from the analysis all patients who died during the first 30 days. After
a mean follow up of 9.6 years, we recorded cardiovascular death. TIMI Risk
Score for STEMI was calculated and they were divided into three groups: Low
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